iQure Pharma Inc.

New Filing
CIK: 0001996977·Other·DELAWARE·Filed: Apr 16, 2024
Total Offering

Indefinite

Amount Sold

$220,000

Investors

7

First Sale

Apr 5, 2024

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2019
Non-Accredited Investors
No

Related Persons

NameRole
Pawel Zolnierczyk
Related Person

Company

iQure Pharma Inc.

475 Wall Street

Princeton, NJ, 08540

3127411606

SEC Filing

0001996977-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
iQure Pharma Inc. Form D Filing — Indefinite | FilingFlow